Bengaluru, July 14 -- which develops, manufactures, and globally markets a broad range of pharmaceutical and biopharmaceutical products gained investor traction after acquisition announcement.

With a market capitalization of Rs 34,309 crore, Emcure Pharmaceuticals Ltd's share on Tuesday made a day high of Rs 1,839.90 per share, up by 2.7 percent from its previous day's close price of Rs 1,792.45 per share. The share of the company gave a return of 33 percent over the last year.

Acquisition Details

Emcure Pharmaceuticals Ltd. has signed share purchase agreements to acquire the remaining 12.05 percent stake in its subsidiary, Gennova Biopharmaceuticals Ltd., from all its individual shareholders. The acquisition involves the purchase of 6...